AME 8-K Current Reports

AMETEK INC/ 8-K Report, Corporate Update (Aug 26, 2026)

AMETEK, Inc. (NYSE: AME) announced on August 26, 2026 that it has completed its previously announced acquisition of a portfolio of instrumentation businesses from Indicor, LLC, in an all-cash transaction valued at $5.0 billion. The filing is a routine Item 8.01 (Other Events) disclosure furnishing a press release as Exhibit 99.1; the 8-K itself contains no detailed financial statements or pro forma data. The acquired Indicor Instrumentation businesses design and manufacture mission-critical solutions for demanding industrial and scientific applications. Management highlights attractive end markets, a substantial recurring revenue base from consumables, services and aftermarket support, and strong alignment with AMETEK's existing portfolio. The businesses will be folded into the Electronic Instruments Group (EIG) and Electromechanical Group (EMG) based on product and market fit. For 2026, the company expects the deal to add approximately $350 million in sales and to be modestly accretive to adjusted earnings. At roughly $5.0 billion, the purchase is significant relative to AMETEK's approximately $9.0 billion annualized sales run rate, and investors will likely focus on integration execution, the return on invested capital versus the price paid, and how the transaction affects leverage and cash deployment.

Aug 26, 2026 8-K

Other Events

AMETEK INC/ 8-K Report, Corporate Update (Aug 11, 2026)

AMETEK, Inc. (AME) announced a significant increase in its commercial paper program, raising the maximum aggregate face amount of outstanding short-term, unsecured commercial paper notes from $2.3 billion to $3.5 billion, an increase of $1.2 billion. This expansion is intended to provide greater financial flexibility, with a stated expectation that the program will be utilized for various purposes, including funding potential acquisitions. The company also confirmed that its existing revolving credit facility will continue to serve as a liquidity backstop for these commercial paper notes, ensuring that total outstanding debt under both facilities does not exceed the new $3.5 billion limit.

Aug 11, 2026 8-K

Material AgreementsFinancial EventsExhibits & Filings

AMETEK INC/ 8-K Report, Financial Results (Aug 4, 2026)

AMETEK reported record second-quarter 2026 results, with sales of $2.04 billion, up 15% year over year. GAAP diluted EPS was $1.77, up 14%, and adjusted diluted EPS was a record $2.09, up 17%. Orders grew 28% for the second consecutive quarter, and operating cash flow rose 35% to $483.7 million, with free cash flow conversion of 111% of net income. Both segments contributed: Electronic Instruments (EIG) sales rose 14% to $1.32 billion with core margin up 40 basis points to 30.1%, and Electromechanical (EMG) sales rose 17% to a record $723.2 million with core margin up 290 basis points. Adjusted operating margin was 26.6%, up 60 basis points, and core operating margin was 27.1%, up 110 basis points. Management raised full-year 2026 guidance. Sales are now expected to grow about 10% versus 2025, and adjusted EPS is now guided to $8.20 to $8.30, up from $7.94 to $8.14, implying 10% to 12% growth. For the third quarter, sales are expected to grow high single digits and adjusted EPS to be $2.08 to $2.10, up 10% to 11%. Acquisitions contributed meaningfully to sales growth, and goodwill rose about $248 million since year-end 2025. Interest expense more than doubled to $30.1 million, partly due to one-time bridge financing fees tied to an acquisition referred to as Indicor, which management excludes from adjusted results. For investors, the quarter shows broad-based organic growth, strong orders momentum, and high cash conversion, alongside an acquisition-driven balance sheet. Total debt declined from about $2.28 billion at year-end 2025 to about $2.04 billion at June 30, 2026, and cash was $495 million. Investors should weigh the non-GAAP adjustments, which exclude about $0.32 per share of acquisition amortization, financing fees, and integration costs, against the GAAP figures.

Aug 4, 2026 8-K

AMETEK INC/ 8-K Report, Material Agreement (Jun 12, 2026)

AMETEK, Inc. (AME) has filed an 8-K detailing significant amendments to its financing structure, primarily related to its upcoming acquisition of Indicor Holdings, LLC. The company has executed an Amended and Restated Credit Agreement, substantially increasing its revolving credit facility to $3.5 billion from $2.3 billion and extending the maturity date to June 9, 2031. This expanded facility can be used for general corporate purposes, including acquisitions, working capital, and refinancing, with up to $1.0 billion earmarked for the Indicor Acquisition. Furthermore, AME has entered into a new Term Loan Credit Agreement providing for up to $4.0 billion across three tranches (maturing in three, four, and five years) specifically to fund the Indicor Acquisition. The funding of these term loans is contingent upon the consummation of the acquisition. These new credit facilities effectively replace previously secured bridge financing for the acquisition, indicating a more stable and long-term funding strategy.

Jun 12, 2026 8-K

AMETEK INC/ 8-K Report, Corporate Update (May 26, 2026)

AMETEK, Inc. (NYSE: AME) announced on May 26, 2026 that it has completed its acquisition of First Aviation Services, a provider of highly engineered defense and aviation maintenance, repair and overhaul (MRO) services that also manufactures related proprietary components. The filing is furnished under Item 8.01 (Other Events) with the press release attached as Exhibit 99.1, so this is a completion announcement rather than a new material agreement or financial restatement. According to the release, First Aviation generates approximately $80 million in annual revenue and operates six centers of excellence across the U.S. Its capabilities include advanced electronics, rotor blades and assemblies, propellers, landing gear, and flight controls, plus design, engineering, and manufacturing of critical parts for defense and aviation platforms. The business will join AMETEK's Electromechanical Group (EMG). CEO David A. Zapico characterized it as a strategic fit with AMETEK's existing MRO business, citing market expansion and added scale in mission-critical aerospace and defense applications. For investors, the deal is modest relative to AMETEK's roughly $7.5 billion in annual sales, equating to about 1% of revenue. The filing does not disclose the purchase price, financing structure, or expected earnings impact, so the transaction's valuation and accretion profile cannot be assessed from this document alone. The acquisition is consistent with AMETEK's stated Strategic Acquisitions growth strategy and its focus on defense and aerospace niche markets.

May 26, 2026 8-K

AMETEK INC/ 8-K Report, Shareholder Vote Results (May 11, 2026)

This 8-K filing reports the results of AMETEK, Inc.'s (AME) Annual Meeting of Stockholders held on May 7, 2026. The primary focus of this filing is the outcome of shareholder votes on key corporate governance matters. Investors will find reassurance in the strong approval for the election of directors and the advisory approval of executive compensation, indicating broad shareholder confidence in the company's leadership and remuneration policies. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the upcoming fiscal year was overwhelmingly ratified, reinforcing the company's commitment to transparent financial reporting and oversight. Specifically, all director nominees presented received substantial "For" votes, with significant margins over "Against" votes. The advisory vote on executive compensation also passed with a strong majority. The ratification of the independent auditor further solidifies the established governance structure. Investors can interpret these results as positive indicators of shareholder alignment with the company's strategic direction and operational integrity.

May 11, 2026 8-K

AMETEK INC/ 8-K Report, Executive Changes (May 8, 2026)

AMETEK, Inc. (NYSE: AME) filed an 8-K on May 8, 2026 announcing that its Board of Directors appointed Nick L. Stanage as an independent director, effective May 7, 2026. He will serve as a Class III director until the 2027 Annual Meeting. The filing is a governance update rather than a financial disclosure: it contains no earnings results, guidance, transaction, or material financial figures. Mr. Stanage brings substantial industrial and aerospace experience. He was Chairman and CEO of Hexcel Corporation, served as Executive Chairman through November 2024, and previously held senior roles at Dana Holding Corporation and a 20-year career at Honeywell. He currently sits on the boards of Hexcel, Huntington Ingalls Industries, and TriMas Corporation. CEO David Zapico described his operating experience as complementary to the existing Board. For investors, the appointment is a modest, generally positive signal of board refresh and aerospace/industrial operating depth, consistent with AMETEK's stated growth model. Compensation is standard for non-employee directors: a $120,000 annual cash retainer and an equity award with a $210,000 target value, both prorated for 2026. The filing does not indicate any change to AMETEK's strategy, financial outlook, or operations.

May 8, 2026 8-K

AMETEK INC/ 8-K Report, Corporate Update (May 6, 2026)

AMETEK (NYSE: AME) announced on May 6, 2026 a definitive agreement to acquire a portfolio of instrumentation businesses from Indicor, LLC ("Indicor Instrumentation") in an all-cash transaction valued at approximately $5.0 billion. The businesses generate roughly $1.1 billion in annual sales, carry profitability consistent with AMETEK, and will be integrated into the Electronic Instruments Group (EIG) and Electromechanical Group (EMG). Management cites a valuation of about 14x EBITDA and expects the deal to be cash earnings accretive in Year 1, with a strong return on capital. The deal is large relative to AMETEK's scale. With annual sales of about $7.5 billion, the target equals roughly 15% of AMETEK's revenue, and the $5.0 billion price is a major capital commitment. Funding will come from borrowings under the existing credit facility plus new debt issuance, with expected leverage at closing of about 2.3x. That leaves less balance sheet headroom for other capital deployment in the near term, though 2.3x is a manageable level for an investment-grade industrial. Investors should watch the pace of deleveraging and the debt pricing that follows. Management highlights roughly 50% aftermarket and recurring revenue, end-market overlap with existing AMETEK businesses, and synergies of 10% to 12% of sales. Those synergy figures are a central part of the value case and warrant scrutiny, since achieving them depends on integration execution. The transaction is subject to customary conditions and regulatory approvals and is expected to close in the second half of 2026. The filing does not disclose the target's EBITDA margin or its standalone growth rate, so those inputs to the valuation cannot be independently verified from this document.

May 6, 2026 8-K

AMETEK INC/ 8-K Report, Financial Results (Apr 30, 2026)

AMETEK reported record first-quarter 2026 results, with net sales of $1.93 billion, up 11% year over year. GAAP diluted EPS was a record $1.74, and adjusted diluted EPS was $1.97, up 13% from $1.75. GAAP operating income rose to $514.9 million, and adjusted operating income increased 14% to $516.6 million, with the operating margin up 50 basis points to 26.8% (the release also cites an adjusted operating margin of 27.9% on a non-GAAP basis). Management highlighted record orders up 23% and a record backlog, with growth coming from both organic sales and recent acquisitions. The Electromechanical Group was a standout, with sales up 13% to a record $663.9 million and operating margin expanding 380 basis points to 25.7%. The Electronic Instruments Group grew sales 11% to $1.26 billion, with adjusted operating income up 6%, and core margin expanded 40 basis points to 31.4%. AMETEK raised its full-year 2026 adjusted EPS guidance to $7.94 to $8.14, up from $7.87 to $8.07, implying 7% to 10% growth, and now expects high-single-digit overall sales growth. For the second quarter, it guided to high-single-digit sales growth and adjusted EPS of $1.96 to $2.00, up 10% to 12%. Separately, AMETEK agreed to acquire First Aviation Services, a defense and aviation MRO and proprietary component provider with about $80 million in annual sales. The deal is subject to customary closing conditions, including regulatory approvals, and its financial terms were not disclosed in the filing. The acquisition is small relative to AMETEK's roughly $7.5 billion revenue base, but it expands the company's MRO and mission-critical component offerings. For investors, the quarter shows strong top-line momentum, expanding margins, and a record backlog, supporting the company's growth model. Points to monitor include the impact of acquisition-related costs and amortization on GAAP versus adjusted earnings, the company's balance sheet capacity for further acquisitions, and whether order strength continues to convert into sales.

Apr 30, 2026 8-K

AMETEK INC/ 8-K Report, Corporate Update (Feb 12, 2026)

AMETEK, Inc. (AME) has announced a significant return of capital to shareholders through an approved 10% increase in its quarterly cash dividend. Effective immediately, the quarterly dividend will rise to $0.34 per share, up from the previous $0.31 per share. This move signals strong confidence from the Board of Directors in the company's financial health and its ability to generate consistent cash flow to support shareholder returns.

Feb 12, 2026 8-K

AMETEK INC/ 8-K Report, Financial Results (Feb 3, 2026)

AMETEK (NYSE: AME) reported record fourth-quarter and full-year 2025 results on February 3, 2026. Q4 sales rose 13% year over year to a record $2.0 billion, and GAAP diluted EPS was a record $1.73, while adjusted EPS was a record $2.01, up 7%. Full-year sales reached $7.4 billion (up 7%), GAAP diluted EPS was $6.40, and adjusted EPS was $7.43 (up 9%). Adjusted operating margin for the year was 26.2%, and the company set annual records for sales, operating profit, margin, EBITDA, and EPS. Cash generation was strong, with Q4 free cash flow of $527.3 million (132% of net income) and record operating cash flow of $584.3 million. Growth was driven by organic sales gains, acquisitions (including Faro Technologies), and operating leverage, with EMG posting a sharp 240 bp margin improvement in Q4. Management guided 2026 sales up mid-to-high single digits and adjusted EPS of $7.87 to $8.07 (6% to 9% growth), with Q1 2026 sales expected up about 10% and adjusted EPS of $1.85 to $1.90. Management cited a record backlog, improving end-market dynamics, and substantial financial flexibility for future acquisitions. Balance sheet changes are notable: goodwill rose to $7.17 billion from $6.56 billion, and short-term debt increased to $1.21 billion from $654 million, while long-term debt fell to $1.07 billion from $1.43 billion, reflecting a reclassification toward current maturities. Total debt was roughly $2.28 billion at year-end, compared with about $2.08 billion a year earlier. The filing also disclosed the acquisition of LKC Technologies, a Germantown, MD maker of portable ophthalmic diagnostic devices for detecting diabetic retinopathy. It will join the Electronic Instruments Group and complement the Ultra Precision Technologies Reichert business. The filing did not disclose the purchase price.

Feb 3, 2026 8-K

AMETEK INC/ 8-K Report, Executive Changes (Nov 10, 2025)

AMETEK, Inc. (NYSE: AME) filed an 8-K on November 10, 2025 to disclose a senior finance leadership transition. Thomas M. Montgomery, Senior Vice President, Comptroller and Principal Accounting Officer, will retire effective January 1, 2026, after 42 years with the company, and will remain as a Senior Advisor through 2026. Robert J. Amodei, currently Vice President and Assistant Controller, will succeed him as Senior Vice President, Controller and Principal Accounting Officer effective the same date. Amodei has been with AMETEK for 36 years and holds CPA and CGMA credentials, and he will be an executive officer in his new role. The filing also covers a related promotion. Scott M. DelOrefice, currently Divisional Vice President, Finance for the Engineered Materials, Interconnects & Packaging division, will become Vice President, Group Controller of the Electromechanical Group effective January 1, 2026. DelOrefice has eight years with AMETEK and previously served as CFO of Asahi Refining North America. For investors, this is a planned, orderly succession announced well ahead of the effective date rather than a disruptive departure. The 8-K contains no financial results, guidance, or changes to the company's accounting policies, and the announcement is framed by management as evidence of internal talent depth. The filing does not disclose any compensation changes for the new officers, so the primary near-term significance is continuity in the finance organization, which is a modest positive for governance and execution.

Nov 10, 2025 8-K

AMETEK INC/ 8-K Report, Financial Results (Oct 30, 2025)

AMETEK (NYSE: AME) reported record third-quarter 2025 results, with sales of $1.89 billion, up 11% year over year, and GAAP diluted EPS of $1.60. Adjusted diluted EPS was a record $1.89, up 14%. GAAP operating income reached a record $488.4 million, or 25.8% of sales. Growth was broad-based: Electronic Instruments Group (EIG) sales rose 10% to $1.25 billion, and Electromechanical Group (EMG) sales rose 13% to $646.3 million, with EMG operating margin expanding 250 basis points to 25.4%, led by Paragon Medical. Management attributed about 90 basis points of margin expansion, excluding recent acquisitions, to the quarter. The FARO Technologies acquisition is contributing, though it carried $19.7 million of pre-tax acquisition-related costs in the quarter. The key forward-looking change is a raised 2025 outlook. Management now expects full-year adjusted EPS of $7.32 to $7.37, up from the prior $7.06 to $7.20 range and representing 7% to 8% growth. Full-year sales growth is still guided to the mid-single digits. For Q4 2025, management expects sales up about 10% and adjusted EPS of $1.90 to $1.95, up 2% to 4% year over year. The implied Q4 EPS growth is much slower than the sales growth, which investors should weigh against the margin and acquisition-cost assumptions. Balance sheet activity points to continued acquisition-driven growth. Goodwill rose to $7.19 billion from $6.56 billion at year-end 2024, and total debt including current portion rose to about $2.46 billion from about $2.08 billion. Cash was $439 million. Stockholders' equity grew to $10.5 billion. Nine-month operating income was $1.40 billion, and interest expense fell sharply to $58.4 million from $91.0 million, supporting earnings. Note that this 8-K furnishes the earnings release under Item 2.02, so the information is not deemed filed under Section 18 of the Exchange Act.

Oct 30, 2025 8-K

AMETEK INC/ 8-K Report, Financial Results (Jul 31, 2025)

AMETEK reported record second-quarter 2025 sales of $1.78 billion, up 2.5% year over year, with operating income up 3% to $461.6 million and operating margin up 20 basis points to 26.0%. GAAP diluted EPS was $1.55, up from $1.45. Adjusted diluted EPS, which excludes after-tax acquisition-related intangible amortization of $0.23, was $1.78, up 7% from $1.66. Growth was driven by the Electromechanical Group (EMG), where sales rose 6% to a record $618.5 million and operating margin expanded 210 basis points to 23.3%. The Electronic Instruments Group (EIG) was roughly flat, with sales up about 1% and a strong 29.7% operating margin, though management noted that customers are slowing decisions amid global trade uncertainty. Management raised full-year 2025 adjusted EPS guidance to $7.06 to $7.20, from $7.02 to $7.18, citing the second-quarter results and the pending acquisition of FARO Technologies. Full-year sales are now expected to grow in the mid-single digits. For the third quarter, management expects mid-single-digit sales growth and adjusted EPS of $1.72 to $1.76, up 4% to 6%. The guidance raise is modest, and it is partly attributable to an acquisition that has not yet been reflected in the reported results. The balance sheet strengthened over the first half. Cash rose to $620 million from $374 million at year-end 2024, while total debt declined to about $1.94 billion from about $2.08 billion. Interest expense fell to $16.9 million from $30.6 million in the prior-year quarter. Stockholders' equity increased to $10.4 billion. Management emphasized that cash generation and balance sheet capacity leave room for acquisitions, and its pipeline is described as strong.

Jul 31, 2025 8-K

AMETEK INC/ 8-K Report, Corporate Update (Jul 21, 2025)

AMETEK, Inc. (NYSE: AME) announced on July 21, 2025 that it has completed its acquisition of FARO Technologies, Inc. The deal was valued at $44.00 per share in cash, or approximately $920 million net of cash acquired. Completion followed FARO shareholder approval and receipt of all required regulatory approvals. As a result of the merger, FARO common stock will no longer trade on Nasdaq. The filing is a routine Item 8.01 (Other Events) disclosure that attaches the closing press release as Exhibit 99.1. It contains no new financial statements, no guidance changes, and no financial results. FARO joins AMETEK's Ultra Precision Technologies Division within the Electronic Instruments Group. FARO is a provider of 3D measurement and imaging solutions, including portable measurement arms, laser scanners and trackers, software, and service offerings. FARO had annual sales of approximately $340 million. Against AMETEK's roughly $7.0 billion in annual sales, the acquisition is modest in scale, adding about 5% to revenue on a pro forma basis. Management characterized the deal as strategic, citing enhanced precision measurement capabilities and expansion into attractive market segments. For investors, the key takeaways are that the transaction is closed, the purchase price is about $920 million, and the acquisition extends AMETEK's position in precision measurement. The filing does not disclose expected synergies, accretion, or financing details. Investors should consult AMETEK's periodic reports and earnings materials for those items. The press release's forward-looking statements flag integration risk and the ability to realize anticipated growth, synergies, and cost savings.

Jul 21, 2025 8-K

AMETEK INC/ 8-K Report, Shareholder Vote Results (May 8, 2025)

AMETEK, Inc. (AME) filed an 8-K on May 7, 2025, detailing the outcomes of its Annual Meeting of Stockholders held on May 6, 2025. The primary focus of this filing is the voting results on key corporate governance matters. Investors will note the overwhelmingly positive outcomes for the election of directors and the advisory approval of executive compensation, indicating strong shareholder confidence in current leadership and compensation practices. The meeting also resulted in the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025. This routine but critical vote reassures investors about the company's commitment to transparent financial reporting and audit oversight. Overall, the results suggest a stable and well-supported governance structure at AMETEK.

May 8, 2025 8-K

AMETEK INC/ 8-K Report, Corporate Update (May 8, 2025)

On May 6, 2025, AMETEK (NYSE: AME) announced a definitive agreement to acquire all outstanding shares of FARO Technologies (Nasdaq: FARO) for $44 per share in cash. The price represents an approximate 40% premium to FARO's May 5, 2025 closing price and values FARO at an enterprise value of roughly $920 million. FARO, a provider of 3D measurement and imaging solutions with annual sales of about $340 million, would be integrated into AMETEK's Ultra Precision Technologies division and combined with its existing Creaform business. The boards of both companies unanimously approved the transaction. Closing is subject to customary conditions, including regulatory approvals and approval by FARO shareholders, and is expected in the second half of 2025. The filing itself is a brief Item 8.01 disclosure that incorporates the press release as Exhibit 99.1, so it does not include detailed financing terms, purchase accounting, or expected synergy figures. For investors, the deal is a bolt-on acquisition relative to AMETEK's roughly $7.0 billion in annual sales, and management cites growth and margin expansion opportunities in attractive markets. Key points to monitor are FARO shareholder approval, antitrust and other regulatory clearances, how the purchase is financed, and the eventual disclosure of the acquired earnings contribution and integration costs.

May 8, 2025 8-K

AMETEK INC/ 8-K Report, Financial Results (May 1, 2025)

AMETEK reported first quarter 2025 results (three months ended March 31, 2025) that were solid overall. Sales were $1.73 billion, essentially flat versus the prior year ($1.736 billion), while operating income rose to $454.8 million from $417.2 million on a GAAP basis. Operating margin was 26.3%, up from 24.0% GAAP (and up 60 basis points versus prior-year adjusted results). GAAP diluted EPS was $1.52 versus $1.34 a year earlier, and adjusted diluted EPS was $1.75, up 7% from $1.64. Free cash flow conversion was 112% of net income. Management cited high single-digit orders growth and strong margin expansion, with the Electromechanical Group delivering record sales of $588.3 million and a 21.9% operating margin. The quarter's GAAP comparisons are flattered by the absence of Paragon integration costs in 2025 (which totaled $29.2 million in Q1 2024). Interest expense fell sharply to $19.0 million from $35.3 million, and reported net income rose to $351.8 million from $310.9 million. Electronic Instruments Group sales declined 1% to $1.14 billion, but its operating margin expanded to 31.0%. The balance sheet strengthened, with cash rising to $399 million, short-term debt falling to $472 million from $654 million, and stockholders' equity increasing to $9.97 billion. Looking ahead, AMETEK reaffirmed its full-year 2025 outlook for overall sales growth of low single digits and adjusted EPS of $7.02 to $7.18, up 3% to 5%. Management acknowledged rising uncertainty from global trade dynamics and tariffs but expects mitigation actions to offset the headwinds. The company characterized first-quarter earnings as solidly above its expectations.

May 1, 2025 8-K

AMETEK INC/ 8-K Report, Corporate Update (Feb 10, 2025)

AMETEK, Inc. (NYSE: AME) announced on February 7, 2025 that its Board approved an 11% increase in its quarterly cash dividend, from $0.28 to $0.31 per share, lifting the indicated annual rate to $1.24. The dividend is payable March 31, 2025 to shareholders of record as of March 14, 2025. The company's Chairman and CEO, David A. Zapico, framed the move as reflecting strong financial position while maintaining a priority on strategic acquisitions as the primary use of cash flow. The Board also authorized a new $1.25 billion share repurchase program, which replaces the prior $1 billion authorization from May 2022 that had roughly $590 million remaining. Taken together, the new authorization represents capacity of about $1.25 billion versus roughly $590 million previously available, a meaningful expansion of buyback flexibility. Management characterized repurchases as opportunistic, so the timing and pace of buybacks will depend on market conditions and capital priorities. For investors, the filing is a capital allocation update rather than an operational one. It signals confidence in cash generation and balance sheet strength, and it reinforces management's stated dual approach of continued acquisitions alongside steadily rising dividends and opportunistic share repurchases. The filing contains no financial results, guidance, or forward-looking operational metrics.

Feb 10, 2025 8-K

AMETEK INC/ 8-K Report, Financial Results (Feb 4, 2025)

AMETEK (NYSE: AME) reported record fourth-quarter 2024 results, with sales of $1.76 billion (up 2% year over year), operating income of $469.0 million (up 5%), and an operating margin of 26.6%, up 90 basis points. Adjusted diluted EPS rose 11% to $1.87, while GAAP EPS was $1.67. Free cash flow reached a record $498.3 million, equal to 129% of net income. For full year 2024, sales grew 5% to $6.94 billion, adjusted EPS grew 7% to $6.83, and the company set annual records across sales, operating income, EBITDA, operating cash flow, free cash flow and EPS. Results were pressured in the Electromechanical Group by normalizing OEM inventory levels, though management noted a second consecutive quarter of strong organic order growth there. Electronic Instruments posted record quarterly operating margin of 31.8%. For 2025, AMETEK guided to low-single-digit sales growth and adjusted EPS of $7.02 to $7.18, representing 3% to 5% growth. First-quarter sales are expected to be roughly flat year over year, with adjusted EPS of $1.67 to $1.69. Management emphasized significant balance sheet capacity for acquisitions. The company also announced the acquisition of Kern Microtechnik, a German maker of ultra-precision machining and optical inspection systems with about EUR 50 million in annual sales, which will join the Electronic Instruments Group. Balance sheet data show debt reduction, with short-term borrowings falling from $1.42 billion to $654 million and long-term debt falling from $1.90 billion to $1.43 billion year over year. The quarter's strong margin and cash flow performance supports AMETEK's long-term double-digit EPS growth objective. Investors will likely focus on whether the modest 2025 sales outlook reflects a cyclical trough in OEM demand, and on how the company deploys its substantial acquisition capacity.

Feb 4, 2025 8-K

Other Events

AMETEK INC/ 8-K Report, Corporate Update (Jan 6, 2025)

AMETEK, Inc. (AME) has announced the establishment of a new commercial paper program with a maximum aggregate principal amount of up to $2.3 billion. This program allows the company to issue short-term, unsecured debt notes with maturities of up to 364 days. The primary stated purpose for this program is to enhance financing flexibility, particularly for potential acquisitions. The company has indicated that its existing revolving credit facility will serve as a liquidity backstop for this commercial paper program, ensuring that total indebtedness under both facilities does not exceed $2.3 billion at any given time. This move by AMETEK suggests a proactive approach to managing its capital structure and positioning itself for growth opportunities. Investors should view this as a strategic financial tool that can provide ready access to funds without the immediate commitment of longer-term debt, potentially allowing for opportunistic financing of strategic initiatives. While no notes are currently outstanding, the establishment of this program signals management's readiness to deploy capital efficiently.

Jan 6, 2025 8-K

AMETEK INC/ 8-K Report, Financial Results (Oct 31, 2024)

AMETEK reported third-quarter 2024 results that beat expectations, with net sales of $1.71 billion, up 5% year over year, and operating income of $445.9 million, up 2%, at a 26.1% operating margin. Operating cash flow rose 3% to $487.2 million, and free cash flow conversion was 135% of net income. GAAP diluted EPS was $1.47, flat year over year, while adjusted EPS of $1.66 rose 1%. Management cited double-digit orders growth and 170 basis points of sequential margin improvement at the Electromechanical Group (EMG), which posted 18% sales growth driven largely by the Paragon acquisition, as reflected in the segment's year-over-year comparison. Management raised the low end of its full-year 2024 adjusted EPS guidance to $6.77–$6.82 (up 6%–7%) from $6.70–$6.80, while keeping full-year sales growth guidance at 5%–7%. For the fourth quarter, the company expects mid-single-digit sales growth and adjusted EPS of $1.81–$1.86, up 8%–11%. Interest expense rose sharply to $25.1 million in the quarter from $18.4 million a year earlier, and nine-month interest expense reached $91.0 million versus $57.7 million, reflecting higher borrowing costs tied to acquisition financing. Separately, AMETEK announced the acquisition of Virtek Vision International, a Waterloo, Canada-based maker of laser projection and AI-enabled inspection systems with approximately $40 million in annual sales. Virtek will join the Electronic Instruments Group and complements the Creaform 3D scanning business. The deal is small relative to AMETEK's roughly $7.0 billion revenue base, so its financial impact is likely modest, though it adds to the company's record of bolt-on acquisitions. Total debt fell to about $2.34 billion from roughly $3.31 billion at year-end 2023, and stockholders' equity rose to $9.55 billion.

Oct 31, 2024 8-K

AMETEK INC/ 8-K Report, Financial Results (Aug 1, 2024)

AMETEK (NYSE: AME) reported second quarter 2024 results on August 1, 2024, with sales of $1.73 billion, up 5% year over year, and record operating income of $447.5 million, up 7%, at a 25.8% operating margin (up 40 basis points). Operating cash flow rose 14% to $381.4 million and free cash flow rose 17% to $360.0 million, with free cash flow conversion of 107% of net income. GAAP diluted EPS was $1.45, while adjusted EPS (excluding after-tax acquisition-related intangible amortization of $0.21) was $1.66, up 6%. The Electronic Instruments Group (EIG) drove the quarter, with sales up 2% and operating margin expanding 320 basis points to 30.3%. The Electromechanical Group (EMG) posted record sales of $581.2 million, up 14%, but its operating income fell to $123.1 million, a 21.2% margin, as OEM customers continued to normalize inventory levels. Management lowered its 2024 outlook. Full-year sales growth is now expected at 5% to 7%, and adjusted EPS guidance is $6.70 to $6.80, up 5% to 7%. The company cited a continuing OEM inventory drawdown through the rest of 2024 and more cautious customers delaying project spending. For the third quarter, management expects mid-single-digit sales growth and adjusted EPS of $1.60 to $1.62, down 1% to 2% year over year. The guidance reduction is the main concern for investors, even though the underlying operating performance was strong. The balance sheet strengthened over the first half of 2024. Short-term borrowings and current debt fell sharply from $1.42 billion at year-end 2023 to $828 million, and stockholders' equity rose to $9.25 billion. Interest expense rose meaningfully, to $30.6 million in the quarter from $18.7 million a year earlier, reflecting higher debt costs. Dividends per share increased to $0.28 from $0.25 in the prior-year quarter.

Aug 1, 2024 8-K

AMETEK INC/ 8-K Report, Shareholder Vote Results (May 8, 2024)

AMETEK, Inc. (AME) filed an 8-K on May 8, 2024, reporting the results of its Annual Meeting of Stockholders held on May 7, 2024. The primary focus of this filing is the outcome of shareholder votes on key governance and corporate matters. All director nominees were elected, and the company's executive compensation plan received advisory approval. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified by shareholders. These outcomes indicate strong shareholder support for the current board composition and executive compensation policies. The ratification of the auditor also signifies continued confidence in the company's financial reporting oversight. For investors, this filing provides reassurance regarding the stability of the board and the alignment of executive pay with shareholder interests, as well as the integrity of the audit process.

May 8, 2024 8-K

AMETEK INC/ 8-K Report, Financial Results (May 2, 2024)

AMETEK (NYSE: AME) reported record first-quarter 2024 results on May 2, 2024, with sales of $1.74 billion, up 9% year over year, and GAAP diluted EPS of $1.34. Adjusted diluted EPS was $1.64, up 10% from $1.49 in the prior-year quarter, after excluding a $29.2 million pre-tax ($0.10 per share) Paragon Medical integration charge and adding back $0.21 per share of after-tax acquisition-related intangible amortization. Adjusted operating income reached a record $446.4 million, with adjusted operating margin of 25.7%, up 30 basis points. Operating cash flow was $410 million and free cash flow conversion was 123%, with free cash flow of $382.6 million. The quarter was driven by the Electronic Instruments Group (EIG), where sales rose 4% to $1.16 billion and operating margin hit a record 30.5%, up 280 basis points. The Electromechanical Group (EMG) grew sales 21% to a record $579.4 million, largely due to acquisitions, but its GAAP operating margin fell to 15.7% from 25.1%. Management attributed the EMG weakness to customer inventory normalization and the dilutive effect of recent acquisitions, and expects a second-half recovery. Notably, GAAP operating margin for EMG excluding Paragon integration costs and acquisition dilution is 24.1%, compared with 25.1% a year earlier. For 2024, AMETEK maintained its outlook for low-double-digit percentage sales growth and raised its adjusted diluted EPS guidance to $6.74 to $6.86, up 6% to 8%, from the prior range of $6.70 to $6.85. For the second quarter, management guided to mid-to-high single-digit sales growth and adjusted EPS of $1.63 to $1.65. Investors should weigh the strong EIG margin expansion and cash generation against the EMG margin compression and the elevated interest expense, which rose to $35.3 million from $20.6 million year over year.

May 2, 2024 8-K

AMETEK INC/ 8-K Report, Corporate Update (Feb 9, 2024)

AMETEK, Inc. (AME) announced a significant increase in its shareholder return through a 12% hike in its quarterly cash dividend. Effective from the next payout, the dividend will rise to $0.28 per share, up from the previous $0.25 per share. This action by the Board of Directors signals confidence in the company's financial health and its ability to generate consistent cash flow to reward its investors. The increase underscores AMETEK's commitment to providing value to its shareholders and reflects a positive outlook on the company's future performance. Investors should view this dividend increase as a positive signal of financial strength and management's confidence in sustained profitability.

Feb 9, 2024 8-K

AMETEK INC/ 8-K Report, Financial Results (Feb 6, 2024)

AMETEK (NYSE: AME) reported record fourth-quarter and full-year 2023 results, furnished under Item 2.02 of Form 8-K. Q4 2023 net sales rose 6.5% year over year to a record $1.73 billion, and operating income rose 12% to a record $445.0 million, with operating margin up 120 basis points to 25.7%. GAAP diluted EPS was $1.48 (up from $1.33), and adjusted diluted EPS was a record $1.68, up about 11% from the prior-year comparable figure. For the full year, sales grew 7% to a record $6.60 billion, operating income rose 14% to $1.71 billion, and adjusted EPS of $6.38 rose 12% from $5.68. Operating cash flow in Q4 was a record $540.7 million, up 40%. Management attributed the results to organic growth, recent acquisitions, and operating improvements, and said it deployed about $2.25 billion on acquisitions in 2023, including Paragon Medical. The Electronic Instruments Group (EIG) drove most of the performance, with Q4 sales of $1.24 billion (up 7%) and operating margin of 29.0% (up 250 basis points). The Electromechanical Group (EMG) posted Q4 sales of $494.7 million (up 6%), though its operating income declined year over year to $112.3 million from $114.5 million, with margin at 22.7%. The balance sheet shows a material increase in leverage: goodwill rose to $6.45 billion from $5.37 billion, and short-term borrowings and current debt jumped to $1.42 billion from $226 million, while long-term debt fell to $1.90 billion from $2.16 billion. Total debt is roughly $3.3 billion against $410 million of cash, so net debt is about $2.9 billion. For 2024, management guided to overall sales growth of low double digits in percentage terms and adjusted diluted EPS of $6.70 to $6.85, an increase of 5% to 7%. For Q1 2024, guidance calls for low double-digit sales growth and adjusted EPS of $1.56 to $1.60, up 5% to 7%. The release does not provide a GAAP-to-adjusted bridge beyond amortization of acquisition-related intangibles, and the guidance reflects management's expectations, which are subject to the risks listed in the forward-looking statements.

Feb 6, 2024 8-K

AMETEK INC/ 8-K Report, Executive Changes (Jan 16, 2024)

AMETEK, Inc. (NYSE: AME) announced on January 16, 2024 that Executive Vice President and Chief Financial Officer William J. Burke will retire effective April 2, 2024, after 36 years with the company, including nearly eight years as CFO. Burke will remain with AMETEK as a Senior Advisor through April 2025 to support a smooth handover of his responsibilities. This is a planned leadership transition rather than a response to a reported problem, and the filing contains no indication of disagreement or financial restatement. The Board of Directors has elected Dalip M. Puri, currently Senior Vice President, Operational Finance, as Executive Vice President and CFO effective April 2, 2024. Puri joined AMETEK in 2017 as Vice President and Treasurer and has since held roles as Vice President, Group Controller, and Vice President and then Senior Vice President of Operational Finance. His background spans corporate finance, treasury, investor relations, and controllership, which the CEO cited as preparation for the role. Because he is an internal promotion, continuity of financial reporting and capital allocation practices is likely, though investors will want to see whether his approach differs from Burke's. The filing states there is no arrangement or family relationship tied to Puri's appointment and that he is not party to any related-party transaction. It also notes that Puri will become an executive officer in his new role. The filing does not disclose changes to compensation, guidance, or financial results, so the event is best viewed as a governance and succession item rather than a direct driver of valuation.

Jan 16, 2024 8-K

AMETEK INC/ 8-K Report, Corporate Update (Dec 11, 2023)

On December 8, 2023, AMETEK, Inc. (NYSE: AME) announced it had completed its acquisition of Paragon Medical, a provider of highly engineered medical components and instruments, from affiliates of American Securities LLC. The all-cash transaction was valued at approximately $1.9 billion. The filing itself is a brief Item 8.01 (Other Events) disclosure that incorporates the press release by reference as Exhibit 99.1, so it contains no detailed financial statements, purchase price allocation, or pro forma results. Paragon brings annual sales of roughly $500 million and will be housed within AMETEK's Electromechanical Group (EMG). Its portfolio includes single-use and consumable surgical instruments and implantable components for orthopedics, minimally invasive surgery, robotic surgery, and drug delivery, sold to blue-chip medical device manufacturers. Management framed the deal as broadening AMETEK's presence in the attractive MedTech industry, consistent with its Strategic Acquisitions growth pillar. For investors, the key takeaways are the scale of the deal relative to AMETEK's over $6.0 billion in annual sales (Paragon adds roughly 8% to revenue on a run-rate basis) and its entry into a higher-margin, faster-growing healthcare niche. The primary items to monitor in subsequent filings are the financing structure, expected contribution to margins and EPS, and any integration or synergy commentary from management.

Dec 11, 2023 8-K

AMETEK INC/ 8-K Report, Financial Results (Oct 31, 2023)

AMETEK reported third-quarter 2023 results that beat expectations on profitability and cash flow. Net sales rose 5% to $1.62 billion, and operating income climbed 14% to a record $438.1 million, lifting operating margin to a record 27.0%, up 220 basis points. Operating cash flow was a record $473 million, up 45% year over year. Adjusted diluted EPS was a record $1.64, up 13%, while GAAP diluted EPS was $1.47. The Electronic Instruments Group (EIG) drove the performance, with sales up 8% and operating margin expanding 360 basis points to 29.5%. The Electromechanical Group (EMG) was weaker, with sales down 2% as inventory normalization weighed on short-term customer demand, though its 26.2% margin remained solid. Management raised full-year 2023 adjusted EPS guidance to $6.31–$6.33, from $6.18–$6.26, representing roughly 11% growth. Full-year sales growth guidance was unchanged at mid-to-high single digits, and Q4 adjusted EPS is expected at $1.61–$1.63, up 6–7%. The balance sheet strengthened, with cash rising to $842 million from $345 million at year-end 2022 and long-term debt declining to $1.86 billion from $2.16 billion. AMETEK also announced two acquisitions. It signed a definitive agreement to acquire Paragon Medical, a medical components and instruments provider with about $500 million in annual sales, for roughly $1.9 billion in cash, subject to regulatory approvals. It also completed the acquisition of Amplifier Research Corp., an RF/microwave amplifier and EMC testing equipment maker with about $60 million in annual sales, which joins EIG. Together, these deals expand AMETEK's medical and EMC testing footprints.

Oct 31, 2023 8-K

AMETEK INC/ 8-K Report, Corporate Update (Sep 7, 2023)

AMETEK, Inc. (NYSE: AME) announced on September 6, 2023 that it completed its acquisition of United Electronic Industries (UEI), a Norwood, Massachusetts-based provider of high-performance data acquisition, test, measurement, simulation and control solutions. The filing is a routine Item 8.01 (Other Events) disclosure furnishing the press release as Exhibit 99.1. The company did not report a purchase price, financing terms, or expected earnings impact in this filing. UEI generates approximately $35 million in annual sales, which is modest relative to AMETEK's more than $6.0 billion in annual sales. The transaction is therefore a small tuck-in acquisition, consistent with the company's stated Strategic Acquisitions growth strategy. UEI will be integrated into the Electronic Instruments Group (EIG) and is described as a strategic fit with the Power Systems and Instruments Division, broadening AMETEK's presence in aerospace, defense, energy and semiconductor end markets such as flight simulation, training, machine health monitoring and automated testing. For investors, the deal is unlikely to be material to AMETEK's overall financial results. Its significance lies mainly in incremental growth in attractive niche markets. Investors seeking deal economics, such as purchase price, multiple paid, or accretion impact, should review AMETEK's subsequent quarterly filings or investor communications, as these details are not included in this 8-K.

Sep 7, 2023 8-K

AMETEK INC/ 8-K Report, Financial Results (Aug 1, 2023)

AMETEK reported record second-quarter 2023 results, with net sales of $1.65 billion, up 9% year over year, including 5% organic growth. Operating income rose 15% to a record $418.8 million, and operating margin expanded 130 basis points to a record 25.4%. GAAP diluted EPS was $1.40, while adjusted diluted EPS (excluding after-tax acquisition-related intangible amortization of $0.17) was a record $1.57, up 14%. Operating cash flow was $335 million, up 42%. Management characterized demand as solid, with a positive book-to-bill ratio and a record backlog. By segment, Electronic Instruments Group (EIG) grew sales 10% to $1.13 billion, with operating margin of 27.1%, while Electromechanical Group (EMG) reached record sales of $511.5 million, up 5%, with operating margin of 26.6%. Margin expansion in both segments drove the consolidated results, supported by operational excellence initiatives. Management raised full-year 2023 adjusted diluted EPS guidance to $6.18–$6.26, from $5.96–$6.10, representing 9%–10% growth. Full-year sales are now expected to rise mid-to-high single digits, and third-quarter sales are expected to grow mid-single digits, with Q3 adjusted EPS guided to $1.56–$1.58. The balance sheet strengthened, with cash rising to $606 million and stockholders' equity up to $8.08 billion, providing capacity for acquisitions. This is a furnished (Item 2.02) filing and contains no new material events beyond the earnings release.

Aug 1, 2023 8-K

AMETEK INC/ 8-K Report, Shareholder Vote Results (May 8, 2023)

AMETEK, Inc. (AME) filed an 8-K report on May 8, 2023, detailing the outcomes of its Annual Meeting of Stockholders held on May 4, 2023. The primary focus of the filing is the voting results on several key corporate governance matters. Investors will find that all director nominees were elected, the company's executive compensation was approved on an advisory basis, and the frequency of future advisory votes on executive compensation was set to be an annual event. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified by the stockholders. These outcomes indicate strong shareholder support for the current board of directors and the company's compensation practices. The decision to hold annual advisory votes on executive compensation aligns with best practices and provides shareholders with a consistent opportunity to voice their opinions on management remuneration. The ratification of the independent auditor also signifies confidence in the firm's oversight of the company's financial reporting.

May 8, 2023 8-K

AMETEK INC/ 8-K Report, Financial Results (May 2, 2023)

AMETEK (NYSE: AME) reported first quarter 2023 results on May 2, 2023 that were strong across the board: net sales of $1.60 billion rose 10% year over year (9% organic), operating income rose 15% to a record $405.5 million, and operating margin reached a record 25.4%, up 120 basis points. Operating cash flow was a record $386.5 million, up 92%. GAAP diluted EPS was $1.32, while adjusted diluted EPS (excluding $0.17 of after-tax acquisition-related intangible amortization) was $1.49, up 12%. Management also cited a record backlog and solid orders growth, signaling continued demand. AMETEK raised its 2023 guidance. Full-year sales are now expected to grow mid to high single digits versus 2022, and adjusted diluted EPS is now projected at $5.96 to $6.10, up from the prior $5.84 to $6.00 range. For Q2 2023, management expects sales growth in the mid to high single digits and adjusted EPS of $1.49 to $1.51. The Electronic Instruments Group (EIG) was the main driver, with sales up 13% and operating margin of 27.7%, while the Electromechanical Group (EMG) grew sales only 2% with operating margin of 25.1%, down from its prior-year level. The filing also disclosed the acquisition of Bison Gear & Engineering Corp., a motion control manufacturer with roughly $80 million in annual sales, which will join EMG. The deal is small relative to AMETEK's roughly $6 billion revenue base, but it adds to the company's automation capabilities. Balance sheet metrics were stable, with cash rising to $399.9 million, total debt of about $2.25 billion, and stockholders' equity of $7.76 billion, leaving meaningful capacity for further acquisitions.

May 2, 2023 8-K

AMETEK INC/ 8-K Report, Corporate Update (Feb 10, 2023)

AMETEK, Inc. (AME) announced a significant increase in its quarterly cash dividend to common stockholders, signaling confidence in its financial performance and commitment to returning value to shareholders. The Board of Directors approved a 14% hike, raising the quarterly dividend from $0.22 to $0.25 per share. This strategic move reflects the company's robust financial health and positive outlook. Investors should view this dividend increase as a strong indicator of AMETEK's ability to generate consistent cash flows and its dedication to enhancing shareholder returns through both capital appreciation and regular income distributions.

Feb 10, 2023 8-K

AMETEK INC/ 8-K Report, Financial Results (Feb 2, 2023)

AMETEK (NYSE: AME) reported record fourth-quarter and full-year 2022 results on February 2, 2023. Fourth-quarter sales rose 8% to a record $1.63 billion, with organic growth of 9%. Operating income increased 10% to a record $398 million, and operating margin expanded 50 basis points to 24.5%. GAAP diluted EPS was $1.33, while adjusted EPS (which adds back after-tax acquisition-related intangible amortization of $0.19) was a record $1.52, up 11% year over year. For the full year, sales reached $6.15 billion (up 11%, with organic growth also at 11%), operating income rose 15% to $1.50 billion, and operating margin expanded 80 basis points to 24.4%. Full-year GAAP diluted EPS was $5.01 and adjusted EPS was $5.68, a 17% increase over 2021. The company ended the year with a record backlog of $3.2 billion. The balance sheet and cash profile remain solid. Total assets were $12.43 billion and stockholders' equity rose to $7.48 billion. Long-term debt declined to $2.16 billion from $2.23 billion, and cash was roughly flat at $345 million. Inventories grew sharply to $1.04 billion from $769 million, a build that investors may want to monitor against future cash conversion. Segment results were strong across both groups: Electronic Instruments (EIG) posted record quarterly sales of $1.16 billion (up 10%) and operating margin of 26.5%, while Electromechanical (EMG) sales were $466 million (up 4%) with margin up 100 basis points to 24.6%. For 2023, management guided to overall sales growth in the mid-single digits and adjusted diluted EPS of $5.84 to $6.00, an increase of 3% to 6% over the comparable 2022 base. For the first quarter of 2023, the company expects mid-single-digit sales growth and adjusted EPS of $1.38 to $1.42, up 4% to 7% year over year. Management also emphasized continued capacity for acquisitions and organic investment. The filing itself is an 8-K furnishing the earnings release under Item 2.02, so the information is not deemed filed for Section 18 purposes.

Feb 2, 2023 8-K

AMETEK INC/ 8-K Report, Financial Results (Nov 1, 2022)

AMETEK reported record third-quarter 2022 results, with net sales of $1.55 billion, up 8% year over year and up 11% organically. Operating income rose 14% to a record $384.5 million, and operating margin expanded 140 basis points to 24.8%. GAAP diluted EPS was $1.29, and adjusted diluted EPS, which excludes acquisition-related intangible amortization, was a record $1.45, up 15% from $1.26 a year earlier. Both segments grew, with Electromechanical posting a record 27.4% operating margin and Electronic Instruments reaching 25.9%. Management raised full-year 2022 guidance for the second time this year. Sales are now expected to rise about 10% versus 2021, and adjusted diluted EPS is now projected at $5.61 to $5.63, up 16%, compared with the prior range of $5.46 to $5.54. For the fourth quarter, management expects mid-single-digit sales growth and adjusted EPS of $1.45 to $1.47, up 6% to 7%. The company also disclosed two acquisitions, Navitar and RTDS Technologies, which together required about $430 million of capital and add roughly $100 million in annual sales to the Electronic Instruments Group. The balance sheet shows inventory up about 33% since year-end 2021, to $1.03 billion, while cash fell to $310 million and total debt was about $2.36 billion. Investors should watch working capital and leverage following the acquisitions, although the quarter's margin expansion and raised guidance point to strong execution despite a volatile macro backdrop.

Nov 1, 2022 8-K

AMETEK INC/ 8-K Report, Executive Changes (Aug 8, 2022)

AMETEK, Inc. (NYSE: AME) filed this Form 8-K to disclose the appointment of Suzanne L. Stefany to its Board of Directors, effective August 3, 2022, as an independent Class III director serving until the 2024 Annual Meeting. The filing contains no financial results, guidance, or material operational changes; it is a governance disclosure. The company stated there is no arrangement or understanding between Ms. Stefany and any other person regarding her appointment. Ms. Stefany will receive compensation under the standard non-employee director program, which includes a $110,000 annual basic retainer paid quarterly and an annual equity award with a target value of $165,000, with her 2022 retainer prorated. Non-employee directors are also reimbursed for Board-related expenses. The incremental cost to shareholders is therefore modest relative to AMETEK's $5.5 billion in 2021 sales. For investors, the appointment is a routine board refresh rather than a signal of a strategic shift. Ms. Stefany brings capital markets, investment management, and governance expertise, which the company's press release frames as complementary to its growth strategy of operational excellence, new product development, global expansion, and acquisitions. Her background as a former Wellington Management analyst and current PJT Partners advisor may be relevant to the Board's oversight of capital allocation and M&A.

Aug 8, 2022 8-K

Material AgreementsFinancial EventsOther Events+1

AMETEK INC/ 8-K Report, Financial Results (Aug 2, 2022)

AMETEK (NYSE: AME) reported record second-quarter 2022 results, with net sales of $1.51 billion, up 9% year over year, and organic sales growth of 12%. Operating income rose 15% to a record $364.8 million, and operating margin expanded 130 basis points to 24.1%. GAAP diluted EPS was $1.22, while adjusted diluted EPS (excluding acquisition-related intangible amortization) was a record $1.38, up 20% from $1.15 in the prior-year quarter. Both segments posted strong growth: Electronic Instruments (EIG) sales rose 10% to $1.03 billion with a 25.8% operating margin, and Electromechanical (EMG) sales rose 7% to a record $486.3 million with a 25.6% margin. Management said end demand remains strong and broad-based, with excellent organic orders growth. Management raised full-year 2022 adjusted diluted EPS guidance to $5.46–$5.54, up from $5.34–$5.44, implying 13–14% growth over 2021. Full-year sales are now expected to be up high single digits. For Q3 2022, the company guided to mid-single-digit sales growth and adjusted EPS of $1.36–$1.38, up 8–10% year over year. The company also noted an increasingly challenging operating environment and continued capacity for acquisitions given its balance sheet and cash flow. The filing is largely a results release furnished under Item 2.02, so the information is not deemed "filed" under Section 18 of the Exchange Act. The release also flags standard risks, including COVID-19 effects, supply chain disruptions, raw material prices, international operations, acquisition integration, and general economic conditions. Investors should note that GAAP EPS of $1.22 is meaningfully below the adjusted figure, and that the gap reflects recurring acquisition amortization that is a normal part of AMETEK's acquisition-driven model.

Aug 2, 2022 8-K

AMETEK INC/ 8-K Report, Material Agreement (May 16, 2022)

AMETEK, Inc. (AME) has announced the completion of an amended and restated revolving credit facility, significantly enhancing its financial flexibility. The agreement, effective May 12, 2022, increases the company's revolving credit facility size from $1.5 billion to $2.3 billion. This substantial increase in available credit provides AMETEK with greater resources for potential investments, acquisitions, or operational needs. Furthermore, the company has terminated its $800 million term loan as part of this new arrangement. While the credit agreement provides enhanced borrowing capacity, it also introduces certain restrictions on allowable additional indebtedness, a detail investors should note when assessing future leverage. The full details of the agreement are available in the filed credit agreement.

May 16, 2022 8-K

Shareholder MattersOther EventsExhibits & Filings

AMETEK INC/ 8-K Report, Shareholder Vote Results (May 6, 2022)

AMETEK, Inc. (AME) filed an 8-K on May 6, 2022, detailing the outcomes of its Annual Meeting of Stockholders held on May 5, 2022, and announcing a significant new share repurchase program. At the meeting, all nominated directors were elected for terms expiring in 2025, indicating strong shareholder confidence in the board's leadership. Additionally, shareholders provided advisory approval for the company's executive compensation, a common practice for publicly traded companies, and ratified the appointment of Ernst & Young LLP as their independent registered public accounting firm for 2022, ensuring continued independent oversight of financial reporting. The most impactful news for investors is the Board of Directors' approval of a new $1 billion share repurchase authorization, effective immediately. This substantial authorization supersedes the previous $500 million program initiated in February 2019, of which approximately $313 million was still available. The new program signals the company's commitment to returning capital to shareholders and its confidence in its financial position and future prospects, likely aiming to enhance shareholder value through a reduction in outstanding shares.

May 6, 2022 8-K

Leadership ChangesOther EventsExhibits & Filings

AMETEK INC/ 8-K Report, Financial Results (May 3, 2022)

AMETEK reported a strong first quarter of 2022, with sales of $1.46 billion, up 20% year over year, and operating income of $353.2 million, up 20%, at a 24.2% operating margin. GAAP diluted EPS was $1.17, while adjusted diluted EPS, which excludes acquisition-related intangible amortization, was $1.33, up 24% from $1.07 a year earlier. Management cited double-digit organic growth, orders up 22% and a record $3.0 billion backlog, indicating solid end-market demand despite supply chain constraints, inflation and COVID-19 lockdowns in China. Both segments grew. Electronic Instruments (EIG) sales rose 25% to $987.8 million with a 24.8% operating margin, aided by organic growth and recent acquisitions. Electromechanical (EMG) sales rose 11% to $470.8 million, and its operating income of $128.2 million was a record, with a record 27.2% margin. AMETEK raised its full-year 2022 adjusted EPS guidance to $5.34–$5.44 from $5.30–$5.42, implying 10–12% growth, and now expects high-single-digit full-year sales growth. For the second quarter, it guided to low-to-mid-single-digit sales growth and adjusted EPS of $1.27–$1.30. The filing is a furnished Item 2.02 report, so the results are not deemed filed under Section 18 of the Exchange Act.

May 3, 2022 8-K

AMETEK INC/ 8-K Report, Executive Changes (Feb 10, 2022)

AMETEK, Inc. (NYSE: AME) filed an 8-K on February 10, 2022 reporting two unrelated corporate actions: the appointment of Dean Seavers to its Board of Directors and a 10% increase in its quarterly cash dividend. Mr. Seavers, former President and Executive Director of National Grid (2015-2020) and a former CEO at Red Hawk Fire & Security and GE Security, will join as an independent Class I director effective February 24, 2022, serving until the 2022 Annual Meeting. He will receive a pro rata share of the $110,000 annual basic retainer for 2022 and an annual equity award with a target value of $165,000 under the standard non-employee director compensation program. The board appointment is a governance event rather than a financial one, and the filing contains no financial statements. The dividend increase is the more substantive item for shareholders. The quarterly dividend rises to $0.22 per share from $0.20, payable March 31, 2022 to holders of record as of March 10, 2022, lifting the indicated annual rate to $0.88 per share. Management attributed the increase to strong cash flow generation and operating results, and reiterated that free cash flow will be deployed primarily toward strategic acquisitions, with the dividend growing consistently alongside that capital deployment strategy. The filing references AMETEK's 2021 sales of $5.5 billion and its stated long-term objectives of double-digit percentage EPS growth over the business cycle and a superior return on total capital. AMETEK remains a component of the S&P 500. Investors should view the dividend hike as a signal of management confidence in cash generation, while the board addition is a routine refresh with limited near-term financial impact.

Feb 10, 2022 8-K

AMETEK INC/ 8-K Report, Financial Results (Feb 3, 2022)

AMETEK, Inc. (NYSE: AME) reported record fourth-quarter 2021 results on February 3, 2022. Net sales rose 25% year over year to $1.50 billion, operating income reached a record $361.2 million (24.0% margin), and GAAP diluted EPS was $1.21. Adjusted diluted EPS, which excludes non-cash acquisition-related intangible amortization, was a record $1.37, up 27%. For full year 2021, sales reached a record $5.55 billion (up 22%), operating margin was 23.6%, and adjusted EPS was $4.85 (up 23%), versus GAAP EPS of $4.25. Growth was broad-based across both segments, with Electronic Instruments (EIG) sales up 29% to a record $1.06 billion, helped by organic growth and five acquisitions completed during the year, and Electromechanical (EMG) sales up 18% to $446.7 million with operating margin expanding 260 basis points to 23.6%. Management guided to a strong 2022: full-year sales up approximately 10% and adjusted EPS of $5.30 to $5.42 (9% to 12% growth), and first-quarter sales up roughly 20% with adjusted EPS of $1.24 to $1.28. Management cited record backlog, robust orders, and continued supply chain challenges. The balance sheet shows goodwill and intangibles rising sharply, to $5.24 billion and $3.74 billion, respectively, reflecting acquisition activity, and cash fell to $347 million from $1.21 billion as the company deployed capital. Investors should weigh the strong organic demand and margin expansion against integration risk from acquisitions, supply chain constraints, and the sizeable gap between GAAP and adjusted earnings driven by amortization. This 8-K furnishes the earnings release under Item 2.02 and is not deemed filed for Section 18 purposes. The figures are unaudited in the release and are presented alongside GAAP reconciliations, which investors should review given the non-GAAP adjustments.

Feb 3, 2022 8-K

Leadership Changes

AMETEK INC/ 8-K Report, Executive Changes (Jan 31, 2022)

This 8-K filing from AMETEK, Inc. (AME) reports the immediate resignation of Ruby R. Chandy from the company's Board of Directors, effective January 31, 2022. The resignation is stated to be for personal reasons and does not stem from any disagreements or controversies with the company. Investors should note that while a board change can sometimes signal underlying issues, the company has explicitly clarified the non-controversial nature of this departure. While this filing is limited in scope and focuses solely on the board composition change, it's important for investors to monitor subsequent filings for any further updates or information that may provide additional context. The absence of any stated disagreement suggests continuity in the company's strategic direction and governance, but maintaining awareness of board and executive changes is a standard practice for diligent investors.

Jan 31, 2022 8-K

AMETEK INC/ 8-K Report, Corporate Update (Dec 1, 2021)

On December 1, 2021, AMETEK, Inc. (NYSE: AME) announced via Form 8-K that it completed its acquisition of Alphasense, a Great Notley, Essex, UK-based designer and manufacturer of gas and particulate sensors used in fixed and portable detection systems. Alphasense's sensors measure oxygen concentration, toxic gases, and volatile organic compounds across industrial, commercial, and environmental applications. The company reports annual sales of approximately £25 million, a relatively small transaction against AMETEK's annualized sales of roughly $5.5 billion. Strategically, the deal fits AMETEK's Electronic Instruments Group (EIG) and expands its presence in the environmental, health and safety (EHS) and air quality sensing markets. CEO David Zapico characterized the business as a highly complementary fit with AMETEK's existing sensor operations. The acquisition is consistent with the company's stated Four Growth Strategies, particularly Strategic Acquisitions, which it pairs with disciplined capital deployment. The filing is informational and does not disclose purchase price, financing terms, or expected earnings impact. Investors should view this as a tuck-in acquisition with limited near-term financial significance, while noting its role in AMETEK's ongoing portfolio expansion toward higher-growth sensing and instrumentation end markets.

Dec 1, 2021 8-K

AMETEK INC/ 8-K Report, Executive Changes (Nov 5, 2021)

AMETEK, Inc. (NYSE: AME) filed an 8-K on November 5, 2021 announcing a leadership transition across two senior roles, both effective January 1, 2022. Timothy N. Jones, President of the Electromechanical Group, will retire after a 42-year tenure with the company. He is succeeded by David F. Hermance, currently Vice President and General Manager of the Measurement, Communications and Testing (MC&T) division, a role he has held since 2015 (the press release says he has led MC&T since 2016). Hermance joined AMETEK in 1991 and has held progressively larger leadership roles, and the company's CEO credited him with strong growth in MC&T, including integration of several acquisitions. The filing also reports the creation of a new Chief Commercial Officer position, filled by Emanuela Speranza, currently Vice President, International. The role is designed to drive accelerated organic sales growth through company-wide commercial excellence initiatives, global marketing communications, and digitalization efforts, while she continues to oversee the company's international infrastructure. Both appointees will join the Executive Office as executive officers. For investors, this is a routine-to-positive governance update rather than a material financial event. The filing contains no financial results, guidance changes, or acquisition news. The most notable signal is the new commercial role, which points to management's emphasis on organic growth alongside AMETEK's stated goal of double-digit EPS growth over the business cycle. Investors may watch whether the new structure improves organic sales performance over the coming quarters, while the orderly succession from a long-tenured executive suggests limited near-term execution risk.

Nov 5, 2021 8-K

AMETEK INC/ 8-K Report, Financial Results (Nov 2, 2021)

AMETEK reported record third quarter 2021 results, with net sales of $1.44 billion, up 28% year over year, and organic sales growth of 17%. Operating income rose 25% to a record $337.6 million, with operating margin of 23.4%. GAAP diluted EPS was $1.10, while adjusted diluted EPS (excluding after-tax acquisition-related intangible amortization of $0.16) was a record $1.26, up 25% from the prior year. Management cited strong, broad-based order growth and a record $2.6 billion backlog, supporting a further raise to 2021 guidance. Both segments contributed. Electronic Instruments (EIG) posted record sales of $981.8 million (up 31%) and operating income of $245.1 million (25.0% margin). Electromechanical (EMG) grew sales 21% to $458.9 million, with operating income up 36% to a record $114.6 million and a record 25.0% margin, up 270 basis points. Growth was supported by organic gains and recent acquisitions. Nine-month net sales reached $4.04 billion, up about 21%. For full-year 2021, AMETEK now expects overall sales growth in the low 20% range (organic growth in the low double digits) and adjusted diluted EPS of $4.76 to $4.78, up from the prior $4.62 to $4.68 range and roughly 21% above 2020 on a comparable basis. Q4 guidance calls for sales up in the low 20% range and adjusted EPS of $1.28 to $1.30. Investors should note that cash fell sharply to $359 million from $1.21 billion at year-end 2020, reflecting acquisition spending that lifted goodwill to $5.18 billion, and that total debt (short-term plus long-term) was about $2.65 billion.

Nov 2, 2021 8-K

AMETEK INC/ 8-K Report, Financial Results (Aug 3, 2021)

AMETEK reported record second-quarter 2021 results, with net sales of $1.39 billion, up 37% year over year, and organic growth of 25%. Operating income rose 39% to a record $316.6 million, and operating margin expanded 40 basis points to 22.8%. GAAP diluted EPS was $1.00, while adjusted diluted EPS, which excludes after-tax acquisition-related intangible amortization of $0.15, was a record $1.15, up 37%. Free cash flow of $263.5 million equaled 114% of net income, and backlog reached a record $2.5 billion, which points to broad-based order strength. Both segments grew strongly. Electronic Instruments (EIG) sales rose 44% to $933.9 million, with operating income up 42% and a 24.3% margin. Electromechanical (EMG) sales rose 24% to $452.4 million, with operating income up 33% to a record $112.4 million and a 24.9% margin, up 170 basis points. Management raised 2021 guidance: sales are now expected to grow about 20% (about 10% organic), and adjusted EPS is now $4.62 to $4.68, up from the prior $4.48 to $4.56. For Q3, management expects sales up in the mid-20% range and adjusted EPS of $1.16 to $1.18. The balance sheet shows the effect of recent deals. Goodwill increased to $5.14 billion from $4.22 billion at year-end 2020, and cash fell to $390.6 million from $1.21 billion. Short-term borrowings rose to $700 million from $132 million. The excerpt does not itemize cash uses, but the goodwill increase is consistent with acquisition activity, which management said it will continue to pursue. Year-to-date GAAP EPS was flat at $1.94 versus the prior year, but the comparison is distorted by $143.9 million of other income in the first half of 2020.

Aug 3, 2021 8-K